Trademark: 97301774
Word
WYVERNA THERAPEUTICS
Status Date
Monday, February 19, 2024
Filing Date
Tuesday, March 8, 2022
Published for Opposition
Tuesday, January 24, 2023
Abandoned Date
Monday, February 19, 2024
42 Clinical research in the field of RNA therapeutics; Medical research; Medical research services; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Conducting scientific feasibility studies; Development of pharmaceutical preparations and medicines; Drug discovery services; Genetic testing for scientific research purposes; Providing medical and scientific research information; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing information in the field of clinical research via a website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others in the field of RNA therapeutics; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Feb 20, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 19, 2024
Abandonment - No Use Statement Filed
Jul 18, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 4, 2023
Extension Of Time To Oppose Process - Terminated
Jan 24, 2023
Extension Of Time To Oppose Received
Jan 24, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2023
Published For Opposition
Jan 4, 2023
Notification Of Notice Of Publication E-Mailed
Dec 21, 2022
Approved For Pub - Principal Register
Dec 21, 2022
Examiner's Amendment Entered
Dec 21, 2022
Notification Of Examiners Amendment E-Mailed
Dec 21, 2022
Examiners Amendment E-Mailed
Dec 21, 2022
Examiners Amendment -Written
Dec 20, 2022
Notification Of Non-Final Action E-Mailed
Dec 20, 2022
Non-Final Action E-Mailed
Dec 20, 2022
Non-Final Action Written
Dec 19, 2022
Letter Of Protest Evidence Reviewed-No Further Action Taken
Dec 18, 2022
Assigned To Examiner
Jun 16, 2022
Letter Of Protest Evidence Forwarded
Mar 14, 2022
New Application Office Supplied Data Entered
Mar 11, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
